Dr. Yin joined Iovance in November 2021. He is a pharmacologist by training with 25 years of discovery and development experience in various therapeutic areas within the biopharmaceutical industry. His prior leadership roles included Vice President of Oncology Research at Pfizer, Executive Director at Novartis, Chief Scientific Officer at Fosun Pharma and President of the Innovation Institute at Qilu Pharmaceutical. Dr. Yin has contributed to the development of widely used therapies during his career such as the cancer therapies Kymriah® (the first CAR-T therapy approved by the US FDA) and Afinitor®, as well as the autoimmune disease therapy Cosentyx®. He earned a Ph.D. in Pharmacology from the University of Rochester and then conducted post-doctoral research in the Department of Biochemistry and Molecular Pharmacology at the University of California, San Francisco.
Links
Sign up to view 0 direct reports
Get started